Oxytocin Makes Time Fly
Oxytocin Makes Time Fly
Can people’s social skills affect their experience of time?
Oxytocin Makes Time Fly
Oxytocin Makes Time Fly

Can people’s social skills affect their experience of time?

Can people’s social skills affect their experience of time?

arthropod, neuroscience, culture
Ten-Minute Sabbatical
Ten-Minute Sabbatical
Emily Cox and Henry Rathvon | Aug 1, 2018
Take a break from the bench to puzzle and peruse.
Officially Intelligent
Officially Intelligent
Bob Grant | Aug 1, 2018
Humanity is on the precipice of major change. Some fear a world ruled by bots. I fear a world ruled by people.
Lessons from Biosphere 2
Lessons from Biosphere 2
Mark Nelson | Aug 1, 2018
Both the scientific community and the general public still have a lot to learn from the largest mesocosm research project ever conducted.
As Brain Organoids Mature, Ethical Questions Arise
As Brain Organoids Mature, Ethical Questions Arise
Ashley Yeager | Aug 1, 2018
Inserting human “mini-brains” into rodents has the potential to broaden scientists’ understanding of neurological disease, but raises quandaries about consciousness.
Infographic: How to Make a Brain Organoid
Infographic: How to Make a Brain Organoid
Ashley Yeager | Aug 1, 2018
Mini-brains can be grown in culture or printed.
Migraine Drug Wins EU Approval
Migraine Drug Wins EU Approval
Ashley Yeager | Jul 31, 2018
Aimovig will soon be available for individuals who have four or more migraines a month.
Monkeys Pass on Brain Activity Patterns Linked to Anxiety
Monkeys Pass on Brain Activity Patterns Linked to Anxiety
Ashley Yeager | Jul 30, 2018
Humans might also inherit such brain changes, a new study suggests.
Image of the Day: Squeeze In
Image of the Day: Squeeze In
Sukanya Charuchandra | Jul 30, 2018
A novel system lets researchers examine the neuromuscular features of a hydra.
Alzheimer’s Drug Slows Symptoms, Reduces Plaques
Alzheimer’s Drug Slows Symptoms, Reduces Plaques
Kerry Grens | Jul 26, 2018
In a clinical trial, patients on the highest injected dose had 30 percent less cognitive decline over time than people on a placebo.